HANDOK Inc.
002390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002390003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로 132, 서울특별시
- Website:
- https://www.handok.co.kr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-16 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.8 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.6 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.9 KB | ||
| 2025-09-16 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.9 KB | ||
| 2025-08-18 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 18.7 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 4.1 MB | ||
| 2025-08-05 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 23.7 KB | ||
| 2025-07-31 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.6 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.4 KB | ||
| 2025-06-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 118.7 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1000.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.7 MB |
Automate Your Workflow. Get a real-time feed of all HANDOK Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HANDOK Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HANDOK Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.
United States of America
PPBT
United States of America
PPBT
Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.
United States of America
PYXS
United States of America
PYXS
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland
CRM
Poland
CRM
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands
QIA
Netherlands
QIA
South Korea
317690
Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.
United States of America
QNTM
United States of America
QNTM
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France
ALQGC
France
ALQGC
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America
QDEL
United States of America
QDEL
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America
QNCX
United States of America
QNCX
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America
QNRX
United States of America
QNRX